Premium
InvAscent, a homegrown private equity firm focused on the healthcare sector, has made a fresh investment in a women’s reproductive healthcare company from its latest fund, the India Life Sciences Fund III. The new transaction comes after InvAscent, which manages assets worth over $500 million, invested $10.5 million (around Rs ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
